Opgn stock forecast.

Suppose an investor wants to buy a stock with a P/E ratio of 30. This means that he is willing to shell out $30 for only $1 worth of earnings as he expects earnings of the company to rise at a ...

Opgn stock forecast. Things To Know About Opgn stock forecast.

What's OPGN's stock forecast? By Ambrish Shah. Mar. 9 2021, Published 9:28 a.m. ET. Source: Unsplash. On Mar. 8, OpGen stock rose 37 percent to close at $2.68. The stock rose after the company ...11 equities research analysts have issued 1 year price targets for Opendoor Technologies' shares. Their OPEN share price targets range from $1.70 to $7.00. On average, they anticipate the company's stock price to reach $3.47 in the next year. This suggests a possible upside of 27.0% from the stock's current price.WebStock Price Forecast. According to 5 stock analysts, the average 12-month stock price forecast for Nkarta stock is $13, which predicts an increase of 392.42%. The lowest target is $9.00 and the highest is $18. On average, analysts rate Nkarta stock as a strong buy.Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research ToolsOPGN 3.34%. Brainstorm Cell Therapeutics Inc. $0.23. BCLI 1.16%. BioCardia Inc. $0.64. BCDA ... A valuation method that multiplies the price of a company's stock by the total number of outstanding ...

Dec 1, 2023 · OpGen last announced its quarterly earnings results on August 10th, 2023. The medical research company reported ($0.93) earnings per share for the quarter, missing the consensus estimate of ($0.71) by $0.22. The business earned $0.74 million during the quarter, compared to the consensus estimate of $0.90 million.

Analyst Future Growth Forecasts. Earnings vs Savings Rate: OPGN is forecast to remain unprofitable over the next 3 years. Earnings vs Market: OPGN is …

NASDAQ: OPGN · IEX Real-Time Price · USD. Add to Watchlist 0.460 +0.005 (1.12%) ... OpGen Stock Forecast. All Analysts Top Analysts Stock Price Forecast.The forecasts range from a low of 3.23 to a high of $63.00. The average price target represents an increase of 4,503.91% from its latest reported closing price of 0.70. See our leaderboard of ...DARE Stock 12 Months Forecast. $3.33. (846.29% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Daré Bioscience in the last 3 months. The average price target is $3.33 with a high forecast of $6.00 and a low forecast of $2.00. The average price target represents a 846.29% change from the last price of $0.35.On October 12, 2023, OpGen Inc (OPGN) stock had a median target price forecast of $3.00, according to data from CNN Money. This represents a significant increase of 67.60% from the last recorded price of $1.79. The high and low estimates for the stock’s price target were also $3.00, indicating a consensus among analysts.If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.

Industry. Pharmaceuticals: Major. No executives to display. Corporate headquarters. --, --. Find real-time MYMD - MyMD Pharmaceuticals Inc stock quotes, company profile, news and forecasts from ...

See OpGen, Inc. (OPGN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

Mullen Automotive stock is so cheap: 3+ reasons to avoid MULN. Mullen Automotive (NASDAQ: MULN) stock price has gyrated recently after the company made some important headlines. The penny stock jumped to a high of $0.9624 in August and then recoiled to $0.3895 on... 2 months ago - Invezz.OPGN | AI Stock Analysis for Opgen Inc OPGN Including Stock Price, Stock Chart, Technical, Fundamental, Sentiment Analysis and More.Home > OPGN Competitors Forecast Fair Value Financials Dividend Market Cap Profile Competitors Analyst Ratings OpGen Competitors. Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts Market Cap; ROG: Roche Holding Outperform 5 CHF293.60 CHF384.23 24.32% 9WebAVXL Stock 12 Months Forecast. $56.00. (692.08% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Anavex Life Sciences in the last 3 months. The average price target is $56.00 with a high forecast of $58.00 and a low forecast of $54.00. The average price target represents a 692.08% change from the last price of $7.07.12 de out. de 2023 ... Stock Price data may be delayed up to 15 minutes. Copyright © 2023. Portions of this content may be copyrighted by Fresh Brewed Media ...Find the latest Sangamo Therapeutics, Inc. (SGMO) stock quote, history, news and other vital information to help you with your stock trading and investing.Mar 12, 2023 · Should You Buy or Sell OpGen Stock? Get The Latest OPGN Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

OpGen, Inc. (NASDAQ:OPGN): Profit margin; Sep 2022: 448.71K-14.69M-3274.85%: Dec 2022: 721.63K-9.97M-1382.02%: Mar 2023: 913.44K-7.02M-768.56%: …Find real-time MYMD - MyMD Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.NASDAQ: OPGN · IEX Real-Time Price · USD. Add to Watchlist 0.460 +0.005 (1.12%) ... OpGen Stock Forecast. All Analysts Top Analysts Stock Price Forecast.Find the latest OpGen, Inc. (OPGN) stock quote, history, news and other vital information to help you with your stock trading and investing. Find real-time OCGN - Ocugen Inc stock quotes, company profile, news and forecasts from CNN Business. See OpGen, Inc. (OPGN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.OPGN Overview Stock Screener Earnings Calendar Sectors Nasdaq | OPGN U.S.: Nasdaq OpGen Inc. Watch list NEW Set a price target alert Closed Last Updated: Nov 27, 2023 …

For OpGen stock forecast for 2031, 12 predictions are offered for each month of 2031 with average OpGen stock forecast of $0.24, a high forecast of $0.25, and a low forecast of $0.22. The average OpGen stock forecast 2031 represents a -47.69% decrease from the last price of $0.455000013113022. For OpGen stock forecast for …Mar 12, 2023 · Should You Buy or Sell OpGen Stock? Get The Latest OPGN Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

Tonix Pharmaceuticals ( TNXP 0.62%) investors are having a bad week. Hot off the heels of a devastating interim analysis from one of its late-stage clinical trials that looks all but doomed to end ...ROCKVILLE, Md., Jan. 11, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and ...See OpGen, Inc. (OPGN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for MyMD Pharmaceuticals Inc have a median target of 1,536.00, with a high estimate of 1,536.00 and a low estimate of 1,536.00. Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.OpGen, Inc. (NASDAQ:OPGN) Q2 2023 Earnings Call Transcript. OpGen, Inc. (NASDAQ:OPGN) Q2 2023 Earnings Call Transcript August 10, 2023 OpGen, Inc. misses on earnings expectations. Reported EPS is ... Find the latest OpGen, Inc. (OPGN) stock quote, history, news and other vital information to help you with your stock trading and investing.

This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of ...

According to 5 stock analysts, the average 12-month stock price forecast for Erasca stock is $10, which predicts an increase of 498.80%. The lowest target is $7.00 and the highest is $15. On average, analysts rate Erasca stock as a strong buy.

Predictions of OPGN stock price for tomorrow. StockInvest.us is a research service that provides financial data and technical analysis of publicly traded stocks.Stock Price Forecast. According to 5 stock analysts, the average 12-month stock price forecast for Nkarta stock is $13, which predicts an increase of 392.42%. The lowest target is $9.00 and the highest is $18. On average, analysts rate Nkarta stock as a strong buy.OpGen Inc share price live 0.450, this page displays NASDAQ OPGN stock exchange data. View the OPGN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the OpGen Inc real time stock price chart below. You can find more details by ...Long term indicators fully support a continuation of the trend. OpGen, Inc. is a microbial genetics analysis company. The Company offers optical mapping services for analysis of microbial, yeast and fungal genomic architecture. OpGen, Inc. headquartered in Gaithersburg, Maryland. minute delay (Cboe BZX is real-time), ET.Should You Buy or Sell OpGen Stock? Get The Latest OPGN Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.Find out all the key statistics for OpGen, Inc. (OPGN), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.12 de out. de 2023 ... Stock Price data may be delayed up to 15 minutes. Copyright © 2023. Portions of this content may be copyrighted by Fresh Brewed Media ...Opgen Inc Stock Forecast. The Opgen Inc Stock Prediction is based on short term trend analysis and is best used for short term swing traders or day traders rather than long term investors.. Get OPGN Trend Analysis OPGN Stock Analysis. OPGN is currently in a downtrend. OPGN is down -10.53% on 11/10/23 and has lost a total of -31.08% in the …

Apr 18, 2015 · Long term indicators fully support a continuation of the trend. OpGen, Inc. is a microbial genetics analysis company. The Company offers optical mapping services for analysis of microbial, yeast and fungal genomic architecture. OpGen, Inc. headquartered in Gaithersburg, Maryland. minute delay (Cboe BZX is real-time), ET. TNXP's stock price has decreased by -78.66% in the past year and price targets may not have had time to catch up. Stock Price Forecast According to 1 stock analyst, the 12-month stock price forecast for TNXP stock stock is $8.00, which predicts an increase of 1,453.40%.Find the latest OpGen, Inc. (OPGN) stock quote, history, news and other vital information to help you with your stock trading and investing. Instagram:https://instagram. what is margin equitybest micro capmost popular stock trading appprivate social club OpGen, Inc. (OPGN) share price prediction for 2023, 2024, 2025, 2026 and 2027. OPGN one year forecast. Opgen stock monthly and weekly forecasts.OpGen Stock Forecast and Price Target. The average price target for OpGen's stock set by recognized analysts recently is $0.47, which would result in a potential upside of approximately 6.82% if it reached this mark. The estimation is based on a high estimate of $0.53 and a low estimate of $0.42. best stocks under dollar5 2023sharkninja ice cream maker opgn stock forecast zacks. OPGN stock quote history news and other vital information to help you with your stock trading and investing. View real-time stock… Tuesday, November 15, 2022 Edit. 2021 rogue sport wallpaper. rogue sport vs rogue 2021. 2022 Nissan Rogue Vs Rogue Sport Rochester Mn November 15, 2022 Edit. do … sgov dividend OpGen Stock Forecast and Price Target. The average price target for OpGen's stock set by recognized analysts recently is $0.47, which would result in a …View the latest OpGen Inc. (OPGN) stock price, news, historical charts, analyst ratings and financial information from WSJ.Oct 12, 2023 · Together we improve patient care and fight AMR through cutting edge molecular microbiology. OpGen, along with its subsidiaries, Curetis and Ares Genetics, develop and commercialize molecular microbiology solutions to help guide clinicians with more rapid and actionable information about life threatening infections to improve patient outcomes.